DISCO PHARMACEUTICALS: ON COMPLETION OF SPECIFIED RESEARCH, ABBVIE TO HAVE OPTION TO EXCLUSIVELY LICENSE SELECTED PROGRAMS FOR FURTHER DEVELOPMENT

Reuters · 2d ago

Please log in to view news